<code id='932AF1D37E'></code><style id='932AF1D37E'></style>

<acronym id='932AF1D37E'></acronym>

<center id='932AF1D37E'><center id='932AF1D37E'><tfoot id='932AF1D37E'></tfoot></center><abbr id='932AF1D37E'><dir id='932AF1D37E'><tfoot id='932AF1D37E'></tfoot><noframes id='932AF1D37E'>

<optgroup id='932AF1D37E'><strike id='932AF1D37E'><sup id='932AF1D37E'></sup></strike><code id='932AF1D37E'></code></optgroup>

<b id='932AF1D37E'><label id='932AF1D37E'><select id='932AF1D37E'><dt id='932AF1D37E'><span id='932AF1D37E'></span></dt></select></label></b><u id='932AF1D37E'></u>

~~<i id='932AF1D37E'><strike id='932AF1D37E'><tt id='932AF1D37E'><pre id='932AF1D37E'></pre></tt></strike></i>~~

Home» knowledge» explore

explore

explore

author：entertainment 2025-09-27 20:37:43 Page View：61

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

advertisement

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Acelyrin, a rare IPO success, stumbles in its first big test
Next article： DIEP, the 'gold standard' of breast reconstruction, is under threat

explore

Psychedelics group wrestles with new pharma identity

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

Regeneron agrees to White House price limits on anti

Regeneron agrees to White House price limits on anti

RegeneronagreedtopricelimitsforanewCovid-19drugthatwillbedevelopedinpartnershipwiththeDepartmentofHe

Jerome Adams on the need for new antivirals for Covid

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

LongtimeBluebirdBioCEONickLeschlyWendyMaeda/TheBostonGlobeSometwoyearsaftersplittingbiotechcompanyBl

read more